Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 6-Coronavirus deaths rise to 6 in Seattle area as U.S. pushes for more testing

Mon, 02nd Mar 2020 15:27

(Adds details on tests for more Seattle area cases, public
health official quotes)

By David Ryder

KIRKLAND, Washington, March 2 (Reuters) - Six people in the
Seattle area have died of the illness caused by the new
coronavirus, health officials said on Monday, as authorities
across the United States scrambled to prepare for more
infections with the emphasis on increasing testing capacity.

Dr. Jeff Duchin, health officer for the Seattle and King
County Public Health agency, announced the increase in
fatalities from the previous two in Washington state.

Eight of the 14 total cases in his jurisdiction are linked
to an outbreak at a nursing facility in the Seattle suburb of
Kirkland, including four deaths, Duchin said at a news
conference.

At least four of the six people who died were either elderly
or had underlying health conditions or both, Duchin said.

The total number of cases detected by the public health
system in Washington state now stands at 18, the most of any
state. In addition to the 14 King County cases, four residents
of nearby Snohomish County have tested positive for the virus,
officials said.

"We expect the number of cases will continue to increase in
the coming days and weeks, and we are taking this situation
extremely seriously," Duchin said.

However, he also said the vast majority of diagnosed
patients have mild to moderate disease and do not need
hospitalization.

In addition to confirmed cases, King County has about 29
potential cases awaiting test results, so the number there could
soon rise, officials said. Tests were being conducted on about
200 samples per day, and health officials said they expect to
boost the number of tests to at least 1,000 a day in the near
future.

Duchin said his county was not recommending school closures
or cancellation of any events at this point.

"You can expect over the next two weeks to hear more from us
about community mitigation measures and the right time to do
it," he said. "We can't expect people to go for months and
months without going to work, without going to school," he said.

As of Sunday, the number of confirmed and presumptive cases
in the United States had risen to 91, the U.S. Centers for
Disease Control and Prevention (CDC) said. Many of those were
among people repatriated to the United States, either from the
Diamond Princess cruise ship previously quarantined in Japan or
from the Chinese city of Wuhan, where the global outbreak
originated.

The number of presumed cases reported by states but not yet
officially confirmed by the CDC stood at 27, up from seven
previously. The CDC will confirm the tests sent by states with
their own diagnostics. So far, 10 states, including California
and New York, have confirmed or presumed cases.

TEST KITS

U.S. stock markets briefly pared gains following the
announcement of an increase in fatalities but closed higher -
the S&P 500 by 4.6%, the Dow Jones by 5% and the NASDAQ by 4.5%.
World stock markets had a weeklong slide last week on
coronavirus fears.

New York Governor Andrew Cuomo welcomed a CDC decision
allowing New York to test for the virus that has killed more
than 3,000 people worldwide since it emerged in China in
December.

"I would like to have a goal of 1,000-tests-per-day capacity
within one week because, again, the more testing, the better,"
Cuomo said at a briefing on Monday.

Federal health officials have said the number of test kits
for coronavirus would be radically expanded in coming weeks. The
United States appeared poised for a spike in cases, partly
because there would be more testing to confirm infections.

Protective gear and test kits were being distributed to U.S.
military facilities with a priority on distribution to the
Korean Peninsula, the chairman of the Joint Chiefs of Staff,
Army General Mark Milley, said at a briefing.

South Korea is one of the hardest hit countries with 4,335
cases and 26 deaths.

U.S. government military laboratories were working to
develop a vaccine, Milley said.

President Donald Trump said his administration has asked
pharmaceutical companies to accelerate work on the development
of a coronavirus vaccine, but provided no details.

Top U.S. health officials have said any vaccine is up to 18
months away and there is no treatment for the respiratory
disease, although patients can receive supportive care.

Trump and his task force on the outbreak were meeting with
drug company executives on Monday afternoon. U.S. health
Secretary Alex Azar said the administration is working on supply
chain challenges for pharmaceutical companies in response to
coronavirus as many active ingredients come from China.

The White House is also expected to meet this week with top
executives from U.S. airlines and the cruise industry over the
impact of the virus to their businesses, two people briefed on
the matter said.

There have been more than 87,000 cases worldwide and nearly
3,000 deaths in 60 countries, the World Health Organization
said.

(Reporting by Steve Gorman in Los Angeles; additional reporting
by Steve Holland, David Shepardson, Susan Heavey, Lisa Lambert,
Makini Brice, David Morgan, Idrees Ali and Phil Stewart in
Washington, Michael Erman and Caroline Humer in New York and
Manas Mishra in Bengaluru, Writing by Grant McCool; Editing by
Bill Berkrot and Jonathan Oatis)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.